Peter Moosmann

Transcriptional Repression by RING Finger Protein TIF1  That Interacts with the KRAB Repressor Domain of KOX1

Peter Moosmann, Oleg Georgiev, Bertrand Le Douarin et al. · Nucleic Acids Research · 1996 · 282 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)

Dieter Koeberle, Daniel Betticher, Roger von Moos et al. · Annals of Oncology · 2015 · 141 citations · Full text

Medicine, Oncology, Pharmacology +10

Comparison of Carotid Arterial Resistive Indices With Intima-Media Thickness as Sonographic Markers of Atherosclerosis

Beat Frauchiger, Hans Peter Schmid, Christian Roedel et al. · Stroke · 2001 · 113 citations · Full text

Medicine, Cardiology, Radiology +17

Cetuximab in Combination With Chemoradiotherapy Before Surgery in Patients With Resectable, Locally Advanced Esophageal Carcinoma: A Prospective, Multicenter Phase IB/II Trial (SAKK 75/06)

Thomas Ruhstaller, Miklos Pless, Daniel Dietrich et al. · Journal of Clinical Oncology · 2011 · 105 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration

Karolin Behringer, Helen Goergen, Horst Müller et al. · Journal of Clinical Oncology · 2016 · 97 citations

Medicine, Oncology, Cancer Survivorship Care +16